Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance: Prospective, Randomized, Open, Blinded Outcome Evaluation, and Feasibility Trial
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms BOSS-Trial I
- 12 Jun 2017 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
- 12 Jun 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.
- 20 Jan 2017 New trial record